Cholestasis with jaundice in the first months of life presents the paediatrician with a difficult diagnostic and management problem. Many causes have been suggested but generally the aetiology is unknown. The prognosis for the affected infant is difficult to ascertain and the overall prognosis contentious. Shiraki et 1955-74, and give an assessment of the survivors who were followed up in 1978.
Materials and methods
During the period all the infants except 2 had been referred to one of four central clinics; these central clinics are referral hospitals for all paediatric departments throughout Norway. The population in Norway during the period was 3i to 4 million and the birth rate averages about 60 000 a year. All the infants in the study were white. Each of them had obstructive jaundice with hepatomegaly or splenomegaly, or both, with pale stools, and dark-coloured urine; so all of them had fairly severe cholestasis. The number of infants so identified must have been almost complete for Norway at that time. The clinical course was studied from each patient's records, and all the survivors (except 2) were followed up in 1978.
The follow-up. When the patients were followed up a family history was taken and the child was given a clinical examination; haematological values and biochemical liver function tests-such as levels of bilirubin, prothrombin time, aspartate transaminase, alanine transaminase, alkaline phosphatase, ornithine transcarbamylase, cholesterol, triglycerides, and serum proteins-were estimated. In all the patients (except 2), fasting serum bile acids were studied, and in some, serum bile acids after a standardised test meal were estimated, as described by Fausa. 6 
Results
A total of 124 patients with cholestasis, as described above, with onset in the first 3 months of life had been admitted to Norwegian paediatric clinics during the period.
Extrahepatic atresia. The incidence of extrahepatic atresia was about 1:1 8 000 live births and the female/male ratio 3:2. All the 64 patients had undergone surgical exploration before age 3 months. In 4 a direct anatomosis between the biliary tree and the intestine had been possible (neither portojejunostomy nor cholecystoportostomy was performed in any patient). Two of these 4 died later of complicating cholangitis, but 2 were apparently cured. The remaining patients developed biliary cirrhosis and all of them had died before reaching age 2 years. In 8 (13 %) an associated malformation was found: congenital heart disease of various types in 7 (one of whom also had intestinal atresia), and hermaphroditism in 1. None of these patients had affected relatives.
Intrahepatic cholestasis. The incidence was about the same as for extrahepatic cholestasis, but the female/ male ratio was roughly the other way round (3:4) . Of the total number of 60 patients, 26 (43 %) were dead ( Table 2 shows the likely aetiological factors, and a known or associated factor was present in 35 (58 %) of them. We also looked for the same factors during the last 10 years of the period (36 patients) and found a possible aetiology in at least 70 %.
The liver status in 1978 in patients alive is shown in Table 3 . Of the patients with a-1-antitrypsin deficiency 2 have had cirrhosis since infancy. Despite this they have developed fairly well with only slight progression of the cirrhosis or none. The 3 patients with merely biochemical abnormalities have shown a steady, but slow improvement over many years, and 2 patients (14 and 23 years old) have made complete recoveries. Only 3 patients with arteriohepatic dysplasia fulfilled our criteria for neonatal cholestasis. A 7-year-old girl is severely affected by liver disease, but her condition will probably improve after the neonatal cholestasis has resolved. The pedigrees of the 6 families with 'other familial cholestasis' are shown in the Figure. The clinical course in the patients has varied considerably; in family 1 two siblings died in early childhood from liver failure, but our 19-year-old patient with liver cirrhosis is still alive. In family 2 both children died early in life with severe cholestasis; one of them developed a hepatoma. In family 3 the patient had neonatal hepatitis. He is now 11-years old and apparently healthy, but with increased postprandial bile acids, a positive lipoprotein X, and a moderate hyperlipaemia. His mother had prolonged jaundice and severe feeding problems throughout her first year oflife. She now has no sign of cholestasis. The patient from family 4 is now 7-years old, and her liver function is normal; her cholestasis gradually subsided, clearing when she was about 3-years old. Her (Table 3) , and some of the other patients have only minimal biochemical abnormalities. Moreover, there seems to be a tendency for the condition of the patient to improve slowly with time if cirrhosis has not developed, so the number of complete recoveries may eventually be even higher than 20%.
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